Clinical Trials

LymphoidMyeloidOther hematologic neoplasm

94 enrolled

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07495631 2026-03-27

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07498465 2026-03-27

A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

29 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06739447 2026-03-23

Hospital Based Continuous Patient Monitoring System

250 enrolled

Wounds and Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07462299 2026-03-10

NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy

110 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07178912 2026-03-09

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07451743 2026-03-05

ACL ALL

100 enrolled

Anterior Cruciate Ligament Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06446661 2026-03-04

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

38 enrolled

Phase 3 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07223190 2026-03-04

AUDAX

560 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

100 enrolled

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07443592 2026-03-02

LAL-2025

330 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07428486 2026-02-23

A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

24 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07374315 2026-02-12

Weight Gain in Pediatric Leukemia Survivors

LymphoidOtherOther hematologic neoplasm

80 enrolled

Leukemia, Health Behavior, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

NCT06991920 2026-02-11

Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage

50 enrolled

Phase 1/2 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07387926 2026-02-04

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07371533 2026-01-28

A-319

18 enrolled

Phase 4 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07320534 2026-01-08

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

124 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT07319481 2026-01-06

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07166549 2025-12-24

BaseCAR-01

12 enrolled

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07301138 2025-12-24

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

23 enrolled

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07301424 2025-12-24

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07283640 2025-12-22

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

20 enrolled

Phase 2/3 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07297914 2025-12-22

FORUM2

1,000 enrolled

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06303687 2025-11-24

VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

4 enrolled

Pain, Procedural, Burns, Pain, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Pain

NCT07227584 2025-11-12

ALL Backbone in AYAs

67 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06570915 2025-10-01

T-ALL-2024

20 enrolled

Phase 1/2 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07175415 2025-09-16

HEM-iSMART E

42 enrolled